XML 41 R12.htm IDEA: XBRL DOCUMENT v3.2.0.727
Earnings (Loss) Per Share Data
6 Months Ended
Jun. 30, 2015
Earnings Per Share [Abstract]  
Earnings (Loss) Per Share Data

The following is a reconciliation of the basic and diluted earnings per share (“EPS”) computations for both the numerator and denominator (in thousands, except per share data):
 
 
Three months ended June 30,
 
Six months ended June 30,
2015:
 
Income (Numerator)
 
Common Shares(Denominator)
 
Per Common
Share Amounts
 
Income (Numerator)
 
Common Shares(Denominator)
 
Per Common
Share Amounts
Basic EPS
 
 
 
 
 
 
 
 
 
 
 
 
Income from continuing operations
 
$
33,970

 
 
 
$
0.35

 
$
111,359

 
 
 
$
1.15

Loss from discontinued operations
 

 
 
 

 

 
 
 

Net income
 
$
33,970

 
96,255

 
$
0.35

 
$
111,359

 
96,487

 
$
1.15

Effect of Dilutive Securities
 
 

 
 

 
 

 
 

 
 

 
 

Convertible securities
 
66

 
8,356

 
 

 
132

 
7,192

 
 

Stock options, units and awards
 

 
601

 
 

 

 
524

 
 

Diluted EPS
 
 

 
 

 
 

 
 

 
 

 
 

Income from continuing operations plus assumed conversions
 
$
34,036

 
 
 
$
0.32

 
$
111,491

 
 
 
$
1.07

Loss from discontinued operations
 

 
 
 

 

 
 
 

Net income plus assumed conversions
 
$
34,036

 
105,212

 
$
0.32

 
$
111,491

 
104,203

 
$
1.07

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three months ended June 30,
 
Six months ended June 30,
2014:
 
Income (Numerator)
 
Common Shares(Denominator)
 
Per Common
Share Amounts
 
Income (Numerator)
 
Common Shares(Denominator)
 
Per Common
Share Amounts
Basic EPS
 
 

 
 

 
 

 
 
 
 
 
 
Income from continuing operations
 
$
61,246

 
 
 
$
0.63

 
$
124,884

 
 
 
$
1.28

Loss from discontinued operations
 
(39,275
)
 
 
 
(0.40
)
 
(39,139
)
 
 
 
(0.40
)
Net income
 
$
21,971

 
96,999

 
$
0.23

 
$
85,745

 
97,777

 
$
0.88

Effect of Dilutive Securities
 
 

 
 

 
 

 
 
 
 
 
 
Convertible securities
 
66

 
8,440

 
 

 
132

 
8,452

 
 
Stock options, warrants, units and awards
 

 
615

 
 

 

 
677

 
 
Diluted EPS
 
 

 
 

 
 

 
 
 
 
 
 
Income from continuing operations plus assumed conversions
 
$
61,312

 
 
 
$
0.58

 
$
125,016

 
 
 
$
1.17

Loss from discontinued operations
 
(39,275
)
 
 
 
(0.37
)
 
(39,139
)
 
 
 
(0.37
)
Net income plus assumed conversions
 
$
22,037

 
106,054

 
$
0.21

 
$
85,877

 
106,906

 
$
0.80



EPS is reported independently for each amount presented. Accordingly, the sum of the individual amounts may not necessarily equal the separately calculated amounts for the corresponding period.

The Company is required to include additional shares in its diluted shares outstanding calculation based on the treasury stock method when the average market price of a share of Omnicare common stock on the New York Stock Exchange for the applicable period exceeds the following amounts:

Convertible Debt
 
Price
3.75% convertible senior subordinated notes, due 2025
 
$26.56
4.00% junior subordinated convertible debentures, due 2033
 
$40.82
3.25% convertible senior debentures, due 2035
 
$77.00
3.25% convertible senior exchange debentures, due 2035
 
$77.00
3.50% convertible senior subordinated notes, due 2044
 
$70.00


Diluted weighted average shares outstanding for the three and six months ended June 30, 2015 and 2014 excludes the impact of an immaterial number of stock options and stock awards with exercise prices that are greater than the average fair market value of the Company’s common stock during the applicable period.